e-learning
resources
Paris 2018
Sunday, 16.09.2018
Studying novel biomarkers in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sputum cytokine profiling according to the type of airway inflammation in obstructive pulmonary diseases
M. Proboszcz (Warsaw, Poland), P. Nejman-Gryz (Warsaw, Poland), M. Paplinska-Goryca (Warsaw, Poland), K. Górska (Warsaw, Poland), R. Krenke (Warsaw, Poland), T. Przybylowski (Warsaw, Poland)
Source:
International Congress 2018 – Studying novel biomarkers in asthma and COPD
Session:
Studying novel biomarkers in asthma and COPD
Session type:
Thematic Poster
Number:
963
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Proboszcz (Warsaw, Poland), P. Nejman-Gryz (Warsaw, Poland), M. Paplinska-Goryca (Warsaw, Poland), K. Górska (Warsaw, Poland), R. Krenke (Warsaw, Poland), T. Przybylowski (Warsaw, Poland). Sputum cytokine profiling according to the type of airway inflammation in obstructive pulmonary diseases. 963
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003
Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008
Blood cytokine expression in patients with chronic obstructive airway diseases (COAD)
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003
Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 325-331
Year: 2002
Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005
Periostin as a marker of Th2-related inflammation in patients with different types of chronic obstructive airway disease
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Airway pathology in asthma
Source: Eur Respir J 2001; 18: 18S-23S
Year: 2001
Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD
Source: Eur Respir J 2012; 40: 1098-1105
Year: 2012
Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
COPD is associated with reduced pulmonary interstitial expression of pentraxin-3
Source: Eur Respir J 2012; 39: 830-838
Year: 2012
Inflammation and infection in chronic obstructive lung disease assessed according to sputum colour
Source: Eur Respir J 2001; 18: Suppl. 33, 153s
Year: 2001
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design
Source: Eur Respir J 2006; 27: 293-299
Year: 2006
Cytokine profiles in the lungs of patients with interstitial and obstructive lung diseases
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
PG6 Assessing and monitoring airway inflammation in asthma andÿchronic obstructive pulmonary disease
Source: Milan 2017 - Educational material
Year: 2017
Chronic sputum production in COPD is a marker for airway inflammation and colonisation
Source: Eur Respir J 2004; 24: Suppl. 48, 306s
Year: 2004
Airway epithelium, lymphocyte, neutrophil and macrophage apoptosis in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept